Related Experiment Video
Updated: Nov 12, 2025

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
765
Emerging systemic antitarget treatment for differentiated thyroid carcinoma.
Neus Basté1,2, Mireia Mora3,4,5, Juan José Grau1,5
1Medical Oncology Department, Hospital Clinic Barcelona.
Current Opinion in Oncology
|March 15, 2021
Summary
New targeted therapies, including neurotrophic tyrosine kinase receptor (NTRK) and rearranged during transfection (RET) inhibitors, offer improved safety profiles for differentiated thyroid carcinoma. Molecular profiling is crucial for accessing these precision medicines.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Differentiated thyroid carcinoma (DTC) treatment has evolved significantly.
- Kinase inhibitors are standard but have adverse effects.
- New targeted therapies show promise with better safety.
Purpose of the Study:
- To review novel systemic treatment strategies for DTC.
- To discuss advancements in understanding DTC molecular biology.
- To highlight the role of molecular profiling in precision medicine.
Main Methods:
- Review of recent clinical trials and scientific literature.
- Analysis of emerging targeted therapies for DTC.
- Evaluation of molecular profiling techniques and their impact.
Main Results:
- NTRK and RET inhibitors represent significant advancements for specific DTC subtypes.
- Newer agents demonstrate improved safety and efficacy.
- Clinical trials are exploring further novel strategies.
Conclusions:
- Precision medicine is becoming central to DTC management.
- Molecular characterization is essential for treatment selection.
- Access to diagnostic tools and targeted therapies is critical.
Related Concept Videos
Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
Tumor Immunotherapy
824
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
824
Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K

